About
Generics, Contract Manufacturing
Areas of Focus
Categories
Contract ManufacturingSmall Molecule PharmaceuticalGeneric DrugContract ManufacturingContract ManufacturingContract ManufacturingContract ManufacturingMidwest
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
116
By Phase
PHASE1: 1PHASE3: 1
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06136884Lead Sponsor
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases
PHASE1Recruiting
86 participants
Started: Nov 2, 2023 · Completed: Jan 27, 2028
NCT05486468Collaborator
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
PHASE3Recruiting
30 participants
Started: Oct 5, 2022 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Baudette, MN, United States
Map
Loading map...